Topical hemostatic agents: a systematic review with particular emphasis on endoscopic application in GI bleeding

AN Barkun, S Moosavi, M Martel - Gastrointestinal endoscopy, 2013 - giejournal.org
Methods A computerized systematic literature review from January 1950 through August
2012, by using OVID MEDLINE, EMBASE, CENTRAL, and ISI Web of Knowledge 5.6 was …

Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat

BZ Haznedaroglu, Y Beyazit, SL Walker… - Critical reviews in …, 2012 - Elsevier
Sustaining hemostasis in clinical hemorrhages is a challenging task and requires extensive
effort to stabilize medically hard-to-treat traumatic injuries. Several hemostatic agents are …

Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage.

E Huri, IC Haznedaroglu, T Akgul, M Astarci… - Saudi Medical …, 2010 - europepmc.org
Objective To investigate the effect of Ankaferd Blood Stopper (ABS), on renal tubular
apoptosis and on expressions of endothelial nitric oxide synthase (eNOS), inducible nitric …

Qualitative/chemical analyses of Ankaferd hemostat and its antioxidant content in synthetic gastric fluids

A Koluman, N Akar, UY Malkan… - BioMed research …, 2016 - Wiley Online Library
Introduction. Ankaferd hemostat (ABS) is the first topical haemostatic agent involving the red
blood cell‐fibrinogen interactions. The antihemorrhagic efficacy of ABS has been tested in …

Prohemostatic and antithrombin activities of Ankaferd hemostat are linked to fibrinogen gamma chain and prothrombin by functional proteomic analyses

D Ozel-Demiralp, N İğci, B Ayhan… - Clinical and Applied …, 2012 - journals.sagepub.com
Ankaferd blood stopper (ABS) is a novel topical hemostatic agent of plant origin registered
for the management of external hemorrhages, in Turkey. The ABS-induced formation of the …

Acute in vitro effects of ABS (Ankaferd Hemostat) on the lymphoid neoplastic cells (B-CLL and RAJI tumor cell lines)

I Akalin, F Okur, İ HAZNEDAROĞLU… - Uhod-Uluslararasi …, 2014 - avesis.hacettepe.edu.tr
ABS (Ankaferd Hemostat) has emerged as a novel haemostatic agent of plant origin. Its
ability to interact with entire proteins including cell surface receptors and/or blood proteins …

A placebo-controlled, randomized, double-blinded, cross-over phase-I clinical study indicating the safety of topical ankaferd hemostat in healthy volunteers

O Balcik, M Koroglu, H Cipil, O Kaftan… - UHOD …, 2012 - avesis.hacettepe.edu.tr
Ankaferd is a folkloric medicinal plant extract which has historically been used as an
hemostatic agent in traditional Turkish medicine. Ankaferd Hemostat (ABS, Ankaferd …

Reversible protease-activated receptor 1 downregulation mediated by Ankaferd blood stopper inducible with lipopolysaccharides inside the human umbilical vein …

A Karabıyık, S Güleç, E Yilmaz… - Clinical and Applied …, 2011 - journals.sagepub.com
Ankaferd Blood Stopper (ABS) is a novel topical hemostatic agent with pleiotropic actions
indicated in clinical hemorrhages. Protease-activated receptor 1 (PAR-1) is located in the …

[PDF][PDF] Surgical and histopathological effects of topical Ankaferd® hemostat on major arterial vessel injury related to elevated intra-arterial blood pressure/Topikal …

AT Ulus, NN Turan, S Özyalçin… - Turkish Journal of …, 2011 - jag.journalagent.com
Objective: The aim of this study was to assess the surgical and histopathological hemostatic
effects of topical Ankaferd blood stopper (ABS) on major arterial vessel injury related to …

[HTML][HTML] Dual diverse dynamic reversible actions of Ankaferd on EPCR and PAI-1 inside vascular endothelial cells with and without LPS

A Karabıyık, E Yılmaz, Ş Güleç, İ Haznedaroğlu, N Akar - 2012 - jag.journalagent.com
OBJECTIVE: Ankaferd Blood Stopper (ABS) comprises a mixture of the plants Thymus
vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum ve Urtica dioica. ABS has been …